Author Correction: The repertoire of mutational signatures in human cancer.

Autor: Alexandrov LB; Department of Cellular and Molecular Medicine, Department of Bioengineering, Moores Cancer Center, University of California, San Diego, CA, USA., Kim J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Haradhvala NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Huang MN; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore., Tian Ng AW; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore., Wu Y; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore., Boot A; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore., Covington KR; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA., Gordenin DA; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA., Bergstrom EN; Department of Cellular and Molecular Medicine, Department of Bioengineering, Moores Cancer Center, University of California, San Diego, CA, USA., Islam SMA; Department of Cellular and Molecular Medicine, Department of Bioengineering, Moores Cancer Center, University of California, San Diego, CA, USA., Lopez-Bigas N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Klimczak LJ; Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA., McPherson JR; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore., Morganella S; Wellcome Sanger Institute, Hinxton, UK., Sabarinathan R; Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain.; National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India.; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Mustonen V; Department of Computer Science, University of Helsinki, Helsinki, Finland.; Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland.; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Rozen SG; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore. steverozen@gmail.com.; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore. steverozen@gmail.com.; SingHealth, Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Singapore. steverozen@gmail.com., Stratton MR; Wellcome Sanger Institute, Hinxton, UK. mrs@sanger.ac.uk.

Publikováno v: Nature [Nature] 2023 Feb; Vol. 614 (7948), pp. E41.